SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'EF2'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CI1_B_EF2B1429_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 10 | SER C 381TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 (-4.1A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.23A | 4ci1B-4tzcC:0.0 | 4ci1B-4tzcC:21.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CI2_B_LVYB1429_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 9 | SER C 381TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 (-4.1A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.23A | 4ci2B-4tzcC:0.0 | 4ci2B-4tzcC:21.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CI3_B_Y70B1429_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 10 | SER C 381TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 (-4.1A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.23A | 4ci3B-4tzcC:0.0 | 4ci3B-4tzcC:21.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TZ4_C_LVYC502_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 9 | SER C 381TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 (-4.1A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.27A | 4tz4C-4tzcC:0.0 | 4tz4C-4tzcC:33.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TZU_A_Y70A504_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.11A | 4tzuA-4tzcC:20.6 | 4tzuA-4tzcC:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TZU_B_Y70B505_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.22A | 4tzuB-4tzcC:20.14tzuC-4tzcC:20.0 | 4tzuB-4tzcC:100.004tzuC-4tzcC:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TZU_C_Y70C504_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.19A | 4tzuB-4tzcC:20.14tzuC-4tzcC:20.0 | 4tzuB-4tzcC:100.004tzuC-4tzcC:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TZU_D_Y70D503_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.18A | 4tzuD-4tzcC:20.3 | 4tzuD-4tzcC:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4V32_A_EF2A151_1 (CEREBLON ISOFORM 4) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 4 / 7 | TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.31A | 4v32A-4tzcC:15.9 | 4v32A-4tzcC:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4V32_B_EF2B151_1 (CEREBLON ISOFORM 4) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 4 / 7 | TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.26A | 4v32B-4tzcC:15.9 | 4v32B-4tzcC:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4V32_C_EF2C151_1 (CEREBLON ISOFORM 4) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 4 / 7 | TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.37A | 4v32C-4tzcC:15.3 | 4v32C-4tzcC:33.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5AMI_B_EF2B151_1 (CEREBLON ISOFORM 4) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 4 / 8 | SER C 381TRP C 382TRP C 388TRP C 402 | EF2 C 502 (-4.1A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A) | 0.27A | 5amiB-4tzcC:15.9 | 5amiB-4tzcC:33.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FQD_E_LVYE1438_1 (PROTEIN CEREBLONCASEIN KINASE IISOFORM ALPHA) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 12 | SER C 381TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 (-4.1A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.21A | 5fqdE-4tzcC:17.15fqdF-4tzcC:2.2 | 5fqdE-4tzcC:33.025fqdF-4tzcC:15.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_A_EF2A501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.14A | 5yizA-4tzcC:19.9 | 5yizA-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_B_EF2B501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.13A | 5yizb-4tzcC:21.1 | 5yizb-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_D_EF2D501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.14A | 5yizD-4tzcC:19.8 | 5yizD-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_E_EF2E501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.23A | 5yize-4tzcC:20.4 | 5yize-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_G_EF2G501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.15A | 5yizG-4tzcC:19.95yizY-4tzcC:20.3 | 5yizG-4tzcC:97.505yizY-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_H_EF2H501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.12A | 5yizh-4tzcC:20.9 | 5yizh-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_J_EF2J501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.15A | 5yizJ-4tzcC:20.8 | 5yizJ-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_K_EF2K501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.22A | 5yizk-4tzcC:20.35yizt-4tzcC:19.8 | 5yizk-4tzcC:97.505yizt-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_M_EF2M501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.24A | 5yizM-4tzcC:20.4 | 5yizM-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_N_EF2N501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.14A | 5yizn-4tzcC:20.8 | 5yizn-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_P_EF2P501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.10A | 5yizP-4tzcC:21.1 | 5yizP-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_Q_EF2Q501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.12A | 5yizq-4tzcC:21.0 | 5yizq-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_S_EF2S501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.12A | 5yizS-4tzcC:21.1 | 5yizS-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_T_EF2T501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.14A | 5yizk-4tzcC:20.35yizt-4tzcC:19.8 | 5yizk-4tzcC:97.505yizt-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_V_EF2V501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.15A | 5yizV-4tzcC:21.0 | 5yizV-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YIZ_Y_EF2Y501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.21A | 5yizG-4tzcC:19.95yizY-4tzcC:20.3 | 5yizG-4tzcC:97.505yizY-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_A_EF2A501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.13A | 5yj0A-4tzcC:19.9 | 5yj0A-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_B_EF2B501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.12A | 5yj0b-4tzcC:21.1 | 5yj0b-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_D_EF2D501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.13A | 5yj0D-4tzcC:19.8 | 5yj0D-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_E_EF2E501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.21A | 5yj0e-4tzcC:20.4 | 5yj0e-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_G_EF2G501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.13A | 5yj0G-4tzcC:19.95yj0Y-4tzcC:20.3 | 5yj0G-4tzcC:97.505yj0Y-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_H_EF2H501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.12A | 5yj0h-4tzcC:20.8 | 5yj0h-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_J_EF2J501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.14A | 5yj0J-4tzcC:20.8 | 5yj0J-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_K_EF2K501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.21A | 5yj0k-4tzcC:20.25yj0t-4tzcC:19.7 | 5yj0k-4tzcC:97.505yj0t-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_M_EF2M501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.21A | 5yj0M-4tzcC:20.3 | 5yj0M-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_N_EF2N501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.13A | 5yj0n-4tzcC:20.7 | 5yj0n-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_P_EF2P501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.10A | 5yj0P-4tzcC:21.1 | 5yj0P-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_Q_EF2Q501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.10A | 5yj0q-4tzcC:21.0 | 5yj0q-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_S_EF2S501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.11A | 5yj0S-4tzcC:21.0 | 5yj0S-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_T_EF2T501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.14A | 5yj0k-4tzcC:20.25yj0t-4tzcC:19.7 | 5yj0k-4tzcC:97.505yj0t-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_V_EF2V501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.14A | 5yj0V-4tzcC:21.0 | 5yj0V-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ0_Y_EF2Y501_1 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.21A | 5yj0G-4tzcC:19.95yj0Y-4tzcC:20.3 | 5yj0G-4tzcC:97.505yj0Y-4tzcC:97.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_A_6ELA501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.18A | 5yj1A-4tzcC:19.8 | 5yj1A-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_B_6ELB501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.15A | 5yj1b-4tzcC:20.9 | 5yj1b-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_D_6ELD501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.18A | 5yj1D-4tzcC:19.8 | 5yj1D-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_E_6ELE501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.23A | 5yj1e-4tzcC:20.5 | 5yj1e-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_G_6ELG501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 8 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.15A | 5yj1G-4tzcC:19.65yj1Y-4tzcC:20.5 | 5yj1G-4tzcC:98.175yj1Y-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_H_6ELH501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.15A | 5yj1h-4tzcC:20.8 | 5yj1h-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_J_6ELJ501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.13A | 5yj1J-4tzcC:20.7 | 5yj1J-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_K_6ELK501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.26A | 5yj1k-4tzcC:20.15yj1t-4tzcC:19.7 | 5yj1k-4tzcC:98.175yj1t-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_M_6ELM501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.24A | 5yj1M-4tzcC:20.5 | 5yj1M-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_N_6ELN501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.13A | 5yj1n-4tzcC:20.6 | 5yj1n-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_P_6ELP501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.13A | 5yj1P-4tzcC:20.9 | 5yj1P-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_Q_6ELQ501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.18A | 5yj1q-4tzcC:20.9 | 5yj1q-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_S_6ELS501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.14A | 5yj1S-4tzcC:20.9 | 5yj1S-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_T_6ELT501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 8 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.21A | 5yj1k-4tzcC:20.15yj1t-4tzcC:19.7 | 5yj1k-4tzcC:98.175yj1t-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_V_6ELV501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 5 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.15A | 5yj1V-4tzcC:20.8 | 5yj1V-4tzcC:98.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJ1_Y_6ELY501_0 (PROTEIN CEREBLON) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 7 | HIS C 380TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.23A | 5yj1G-4tzcC:19.65yj1Y-4tzcC:20.5 | 5yj1G-4tzcC:98.175yj1Y-4tzcC:98.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H0G_E_Y70E502_0 (PROTEIN CEREBLONZINC FINGER PROTEIN692) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 12 | HIS C 380SER C 381TRP C 388TRP C 402PHE C 404 | EF2 C 502 ( 4.9A)EF2 C 502 (-4.1A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.89A | 6h0gE-4tzcC:9.26h0gF-4tzcC:undetectable | 6h0gE-4tzcC:17.436h0gF-4tzcC:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H0G_E_Y70E502_0 (PROTEIN CEREBLONZINC FINGER PROTEIN692) |
4tzc | PROTEIN CEREBLON (Musmusculus) | 5 / 12 | SER C 381TRP C 382TRP C 388TRP C 402PHE C 404 | EF2 C 502 (-4.1A)EF2 C 502 ( 3.2A)EF2 C 502 (-3.5A)EF2 C 502 (-3.8A)EF2 C 502 (-4.5A) | 0.27A | 6h0gE-4tzcC:9.26h0gF-4tzcC:undetectable | 6h0gE-4tzcC:17.436h0gF-4tzcC:20.73 |